Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Adams

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Orthopedics|March 25, 2009
The pharmacological management of skeletal-related events from metastatic tumorsAnna Hitron, Val Adams
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 24, 2021
Alternate dosage formulations of oral targeted anticancer agentsCharlotte Wagner, Val Adams, Colleen Overley
Cancer Epidemiology|March 16, 2012
The influence of antidiabetic medications on the development and progression of prostate cancerAnna Hitron, Val Adams, Jeff Talbert, et al.
Cell Transplantation|February 28, 2022
Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant PopulationDylan Barth, Michael Singleton, Gregory Monohan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 7, 2010
Blood pressure control in patients receiving bevacizumab in an outpatient cancer centerSal Bottiglieri, Benyam Muluneh, Stephanie Sutphin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 9, 2010
Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumorsAnna Hitron, Doug Steinke, Stephanie Sutphin, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 22, 2019
Multiple sclerosis outcomes after cancer immunotherapyCatherine R Garcia, Rani Jayswal, Val Adams, et al.
Chembiochem : a European Journal of Chemical Biology|December 2, 2006
Generation of new landomycins with altered saccharide patterns through over-expression of the glycosyltransferase gene lanGT3 in the biosynthetic gene cluster of landomycin A in Streptomyces cyanogenus S-136Lili Zhu, Andriy Luzhetskyy, Martha Luzhetska, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 8, 2023
Impact of relative dose intensity on pathologic complete response in human epidermal growth factor receptor 2 positive breast cancer patients receiving neoadjuvant TCHPKaylyn Collette, Cassandra L Perkey, Val Adams, et al.
The Oncologist|March 30, 2023
Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine TumorsYue Cheng, Lowell Anthony, Chris Delcher, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Orthopedics|March 25, 2009
The pharmacological management of skeletal-related events from metastatic tumorsAnna Hitron, Val Adams
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 24, 2021
Alternate dosage formulations of oral targeted anticancer agentsCharlotte Wagner, Val Adams, Colleen Overley
Cancer Epidemiology|March 16, 2012
The influence of antidiabetic medications on the development and progression of prostate cancerAnna Hitron, Val Adams, Jeff Talbert, et al.
Cell Transplantation|February 28, 2022
Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant PopulationDylan Barth, Michael Singleton, Gregory Monohan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 7, 2010
Blood pressure control in patients receiving bevacizumab in an outpatient cancer centerSal Bottiglieri, Benyam Muluneh, Stephanie Sutphin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 9, 2010
Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumorsAnna Hitron, Doug Steinke, Stephanie Sutphin, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 22, 2019
Multiple sclerosis outcomes after cancer immunotherapyCatherine R Garcia, Rani Jayswal, Val Adams, et al.
Chembiochem : a European Journal of Chemical Biology|December 2, 2006
Generation of new landomycins with altered saccharide patterns through over-expression of the glycosyltransferase gene lanGT3 in the biosynthetic gene cluster of landomycin A in Streptomyces cyanogenus S-136Lili Zhu, Andriy Luzhetskyy, Martha Luzhetska, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 8, 2023
Impact of relative dose intensity on pathologic complete response in human epidermal growth factor receptor 2 positive breast cancer patients receiving neoadjuvant TCHPKaylyn Collette, Cassandra L Perkey, Val Adams, et al.
The Oncologist|March 30, 2023
Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine TumorsYue Cheng, Lowell Anthony, Chris Delcher, et al.
Pageof 2